토글닫기
팝업닫기

Refusal of Unauthorized Collection of E-mail Addresses

We do not allow the unauthorized collection of e-mail addresses listed on our website. Persons engaging in unauthorized collection with e-mail address collection programs or other technical devices will be subject to criminal prosecution in accordance with the Act on Information & Communications Network Utilization and Information Protection.

Contact Us

Platform Technology

RNAi platform development

Lead compound discovery

Pulmonology / Neurology

Pharmacological research on OliX RNAi compounds for respiratory and neurological diseases

Ophthalmology

Pharmacological research on OliX RNAi compounds for ocular diseases

Animal Research

Testing efficacy of oligonucleotide therapeutics using animal models

Analytics

Develop analytical methods for therapeutic candidates to determine purity and stability in support of nonclinical and clinical studies

PK/TK

Develop bioanalytical methods to quantitate therapeutic candidates in biological matrices for pharmacokinetic and toxicokinetic (PK/TK) studies

CMC

Manage manufacturing, analytics and quality of therapeutic candidates

Toxicology

Conduct safety evaluation and toxicokinetic assessment of therapeutic candidates through nonclinical studies

Clinical

Establish clinical development plans for therapeutic candidates and conduct clinical studies

Management

HR Management/Regulations Maintenance

Business Management

Purchase/General affairs

Accounting & Finance

Make official announcements about business contents, financial condition, business performance etc.

Stabilize Internal Accounting Control System

IT

IT Infrastructure Management

IT Helpdesk

Legal Affairs

Prevent, respond, handle legal disputes

Provide risk management and compliance support

Develop IP strategies for core technologies

Quality Assurance(QA)

Verify pharmaceutical R&D processes and results

Ensure product to meet the established quality standards

Planning

Develop plans to materialize strategy and analyze business proposals

Assess the company’s operational and strategic performance

Provide support and insight into significant organizational changes

Business Development

Collaborate with global partners on potential out-licensing deals

Establish global marketing strategies (marketability, feasibility)

Establish new business and collaboration plans

Communication

Provide investment information in a timely manner to increase company value

Promote management activities and establish internal/external communication strategies

Create positive corporate culture through various in-house activities and employee education

  • Home
  • PR

PR

News

News

게시물 목록
No. Title Date View
24
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

  • 2021-02-15
  • 조회수 : 493
 2021-02-15 493
23
OliX Pharmaceuticals Launches New Subsidiary to Develop mRNA Vaccines and Therapeutics

OliX Pharmaceuticals Launches New Subsidiary to Develop mRNA Vaccines and Therapeutics

  • 2021-02-09
  • 조회수 : 357
 2021-02-09 357
22
OliX Pharmaceuticals Announces Completion of $37.2 Million Capital Raise

OliX Pharmaceuticals Announces Completion of $37.2 Million Capital Raise

  • 2020-12-04
  • 조회수 : 683
 2020-12-04 683
21
OliX Announces FDA Clearance of the Phase 2a Clinical Trial IND for Hypertrophic Scars

OliX Announces FDA Clearance of the Phase 2a Clinical Trial IND for Hypertrophic Scars

  • 2020-11-13
  • 조회수 : 530
 2020-11-13 530
20
OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa

OliX Pharmaceuticals Announces Expansion of Collaboration with Laboratoires Théa

  • 2020-10-21
  • 조회수 : 627
 2020-10-21 627
19
OliX Moves Into Spotlight Amid Strong RNAi Interest, New Platform file

OliX Moves Into Spotlight Amid Strong RNAi Interest, New Platform file

  • 2020-09-08
  • 조회수 : 725
 2020-09-08 725
18
OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies

OliX Pharmaceuticals Signs Agreement with LGC Biosearch Technologies

  • 2020-06-12
  • 조회수 : 907
 2020-06-12 907
17
OliX Pharmaceuticals Expands Scientific Advisory Board with Addition of Leading Liver Experts

OliX Pharmaceuticals Expands Scientific Advisory Board with Addition of Leading Liver Experts

  • 2020-04-17
  • 조회수 : 1157
 2020-04-17 1157
16
OliX and AM Chemicals Announce Exclusive Licensing and Supply Agreement for GalNAc Technology

OliX and AM Chemicals Announce Exclusive Licensing and Supply Agreement for GalNAc Technology

  • 2020-03-31
  • 조회수 : 1077
 2020-03-31 1077
15
OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs

OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs

  • 2020-03-21
  • 조회수 : 1048
 2020-03-21 1048
14
OliX Pharmaceuticals Announces Publication of Peer Reviewed Study in Molecular Pharmaceutics

OliX Pharmaceuticals Announces Publication of Peer Reviewed Study in Molecular Pharmaceutics

  • 2020-03-13
  • 조회수 : 842
 2020-03-13 842
13
Updated Data_OLX301A

Updated Data_OLX301A

  • 2019-05-23
  • 조회수 : 2219
 2019-05-23 2219
12
OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pi

OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pi

  • 2019-05-10
  • 조회수 : 3195
 2019-05-10 3195
11
OliX Pharmaceuticals Announces Harvard retina specialist Demetrios G. Vavvas, M.D., Ph.D., to join S

OliX Pharmaceuticals Announces Harvard retina specialist Demetrios G. Vavvas, M.D., Ph.D., to join S

  • 2019-04-22
  • 조회수 : 3734
 2019-04-22 3734
10
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD

  • 2019-03-18
  • 조회수 : 2766
 2019-03-18 2766
9
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy.

OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy.

  • 2019-01-18
  • 조회수 : 2601
 2019-01-18 2601
8
OliX’s #RNAi therapy gets approval for phase 2 trials

OliX’s #RNAi therapy gets approval for phase 2 trials

  • 2018-11-14
  • 조회수 : 2553
 2018-11-14 2553
7
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing

OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing

  • 2018-07-23
  • 조회수 : 2494
 2018-07-23 2494
6
CTA approval for Phase 1 in UK

CTA approval for Phase 1 in UK

  • 2018-05-30
  • 조회수 : 2776
 2018-05-30 2776
5
OliX Pharmaceuticals Designates Guangzhou RiboBio a Preferred Oligonucleotide Manufacturer

OliX Pharmaceuticals Designates Guangzhou RiboBio a Preferred Oligonucleotide Manufacturer

  • 2018-05-30
  • 조회수 : 3128
 2018-05-30 3128